// App-Quantinova.ai

TCT-727 : Propensity score matched all comers population treated with ultra-thin strut bare metal and sirolimus-probucol coated drug-eluting stents of identical stent architecture

Researchers

Presenter

  • Markus Florian Krackhardt

Principal Investigators

  • Matt Waliszewski

  • Christian Sperling

  • Tay Mok Heang

  • Mohd Ali Rosli

  • Behrouz Kherad

  • Pedro Sousa

  • Andre Schneider

Medical Centers

  • Klinikum Esslingen, Esslingen, Germany

  • Charite, Berlin, GERMANY

  • Universitätsklinikum Jena, Germany, Ayer Keroh, Malaysia

  • B.Braun Melsungen AG, Berlin, Germany

  • National Heart Institute, Kuala Lumpur, Malaysia

  • B.Braun Vascular Systems, Berlin, Germany

  • Charite University Hospital Berlin, Augustenburger Platz, Germany

  • Hosp de Santa Cruz, Lisbon, Portugal

Locations

  • Germany

  • Malaysia

  • Portugal

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

  • Rapacan

  • Probucol

Outcome

  • N/A

Study Design

  • Observational

  • Single Arm

  • Multinational

  • Multicenteric

Phase

  • NA

Study Id's

  • NCT02629575

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved